Skip to main content
. 2021 Dec 9;12:784028. doi: 10.3389/fimmu.2021.784028

Table 1.

Study inclusion and exclusion criteria according to study groups.

Criteria COVID-19 Pneumonia COVID-19 ARDS Community acquired pneumonia (bacterial origin) Sepsis induced ARDS Healthy controls
Inclusion Positive nasal swap for SARS-CoV-19 virus (SARS-CoV-2-RNA PCR test, RdRP-Gen IP4) with typical symptoms for COVID-19 infection.
CURB-65 ≥1 and clinical symptoms like fever, cough and dyspnea.
Positive nasal swap for SARS-CoV-19 virus
Radiologic evidence of pulmonary involvement by CT-scan
Mechanical ventilation because of ARDS
community acquired pneumonia without recent hospitalization or association with other healthcare facilities such as nursing homes, dialysis centers, and outpatient clinics.
CURB-65 ≥1 and clinical symptoms like fever, cough and dyspnea.
Sepsis or septic shock according to Sepsis-3 criteria (16)
ARDS according to Berlin criteria (4)
Charlson Comorbidity Index = 0 (17)
Exclusion No consent given by individuals or next-of-kin
Age <18
Pregnancy
Preexisting chronic infectious disorders (e.g., endocarditis, HIV or hepatitis)
Current tumor or malignant disorders
Limited patient’s life expectancy <6 months (independent of e.g., sepsis/SIRS, pneumonia or localized infection)
Immunosuppression or steroid therapy (e.g., autoimmune disease, transplantation)

Confusion, Urea, Respiratory Rate, Blood Pressure and Age (CURB-65) score for pneumonia severity (18).